$73.22
-1.23(-1.65%)
52W $30.14 – $79.91
AI-generated
BridgeBio Pharma, Inc.
Revenue breakdown: License And Service (53.5%), Product (40.1%), License Services And Royalty (5.1%).
$14.2BMkt Cap
$493MRev TTM
-$717MNI TTM
-18.8xP/E TTM
What Changed Recently
Fundamentals
How The Business Makes Money
Revenue by Segment
License And Service53.5%($984M)
Product40.1%($738M)
License Services And Royalty5.1%($94M)
Royalty1.3%($23M)
Analyst View
Company Profile
CIK0001743881
ISINUS10806X1028
CUSIP10806X102
Phone650 391 9740
Address421 Kipling Street, Palo Alto, CA, 94301, US
SEC EDGAR